Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma

This study aimed to determine if the immunoscore (IS) staging system would be a potential prognostic factor in hepatitis B virus-related hepatocellular carcinoma (HBV-HCC) in China. IS was performed in a consecutive cohort of HBV-HCC patients (n= 92). CD3+, CD8+, and CD45RO+ T cells were quantified...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Qinwei, Bao, Xuli, Xue, Ran, Liu, Hui, Liu, Haixia, Li, Juan, Dong, Jinling, Duan, Zhonghui, Ren, Meixin, Zhao, Juan, Song, Qi, Yu, Hongwei, Zhu, Yueke, Lu, Jun, Meng, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413257/
https://www.ncbi.nlm.nih.gov/pubmed/28445292
http://dx.doi.org/10.1097/MD.0000000000006735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413257/
https://www.ncbi.nlm.nih.gov/pubmed/28445292
http://dx.doi.org/10.1097/MD.0000000000006735

Ejemplares similares